Fredun Pharmaceuticals share price rose over 3.5% following strong Q1 FY27 results, with net profit increasing 94.1% YoY to ₹13.13 crore. Revenue surged 90.7% YoY to ₹227.75 crore, while total expenses increased primarily due to rising raw material costs and other factors.
Fredun Pharmaceuticals share price rose over 3.5% following strong Q1 FY27 results, with net profit increasing 94.1% YoY to ₹13.13 crore. Revenue surged 90.7% YoY to ₹227.75 crore, while total expenses increased primarily due to rising raw material costs and other factors.
<iframe src="https://hindustansphere.com/embed/cluster/312bc4f528d886ad0a5a09388adc10b0791c94e3" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="778% rally in five years! Multibagger pharma stock close to record high after Q1 results 2026"></iframe>
